News
-
-
-
COMMUNIQUÉ DE PRESSE
GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug
EndoPure Life Sciences to finance first-in-human clinical trials for GB Sciences' cannabinoid-based products through exclusive licensing deal. Aging populations drive global demand for treatments of neurological disorders -
-
-
COMMUNIQUÉ DE PRESSE
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences partners with Endopure Life Sciences for licensing deal on cannabinoid-based treatments for neurological disorders in Brazil and South America, addressing growing market demand -
-
-
-
